The advertisement promotes NUBEQA® (darolutamide) as a treatment option for patients experiencing rising PSA levels while on ADT (androgen deprivation therapy).
Creative Information
| CID: | 134ed719-5383-43f7-9d71-d7cfb64ea306 |
| CRID: | 82_1075-793607 |
| Domain: | nubeqa-us.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $2.08 |
| Timestamp: | 11/1/2025, 4:44:56 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/1/2025, 5:42:16 AM | 4.82s | |
| adomain_analysis | success | 11/1/2025, 6:23:03 AM | 2.76s | |
| adomain_capture | success | 11/1/2025, 6:23:00 AM | 0.10s | |
| ad_render | success | 11/1/2025, 5:42:11 AM | 24.98s | |
| brand_mapping | success | 11/1/2025, 4:44:56 AM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Nubeqa
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1165.70 KB | ||||||||||||||||||||||
| Render Time: | 9.35 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1165.75 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


